Philip E. Dubé

1.3k total citations
22 papers, 1.0k citations indexed

About

Philip E. Dubé is a scholar working on Genetics, Surgery and Oncology. According to data from OpenAlex, Philip E. Dubé has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Philip E. Dubé's work include Helicobacter pylori-related gastroenterology studies (6 papers), Immune Response and Inflammation (6 papers) and Inflammatory Bowel Disease (5 papers). Philip E. Dubé is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (6 papers), Immune Response and Inflammation (6 papers) and Inflammatory Bowel Disease (5 papers). Philip E. Dubé collaborates with scholars based in United States, Canada and France. Philip E. Dubé's co-authors include Patricia L. Brubaker, Thomas A. Ferguson, D. Brent Polk, Thomas S. Griffith, Jasmine Bahrami, M. Kay Washington, Shivesh Punit, Katherine Rowland, Fang Yan and Cambrian Y. Liu and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Philip E. Dubé

22 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip E. Dubé United States 15 290 250 230 189 174 22 1.0k
Hatem Masmoudi Tunisia 22 276 1.0× 87 0.3× 546 2.4× 207 1.1× 164 0.9× 124 1.5k
Songyan Deng United States 19 195 0.7× 460 1.8× 554 2.4× 446 2.4× 261 1.5× 24 1.3k
Jose Zavala‐Solorio United States 13 465 1.6× 279 1.1× 225 1.0× 127 0.7× 156 0.9× 18 1.0k
Toshiaki Teratani Japan 18 354 1.2× 159 0.6× 210 0.9× 95 0.5× 130 0.7× 37 1.1k
Brooks Scull United States 16 595 2.1× 272 1.1× 256 1.1× 223 1.2× 96 0.6× 28 1.3k
Ann Jagger United States 12 328 1.1× 179 0.7× 825 3.6× 70 0.4× 86 0.5× 12 1.8k
David Moulin France 20 384 1.3× 241 1.0× 524 2.3× 182 1.0× 36 0.2× 45 1.3k
V. E. Eysselein United States 16 194 0.7× 408 1.6× 192 0.8× 147 0.8× 96 0.6× 37 981
Blake M. Warner United States 18 313 1.1× 88 0.4× 153 0.7× 55 0.3× 47 0.3× 61 1.0k
Ulrika Islander Sweden 23 733 2.5× 83 0.3× 518 2.3× 438 2.3× 97 0.6× 56 1.7k

Countries citing papers authored by Philip E. Dubé

Since Specialization
Citations

This map shows the geographic impact of Philip E. Dubé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Dubé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Dubé more than expected).

Fields of papers citing papers by Philip E. Dubé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip E. Dubé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Dubé. The network helps show where Philip E. Dubé may publish in the future.

Co-authorship network of co-authors of Philip E. Dubé

This figure shows the co-authorship network connecting the top 25 collaborators of Philip E. Dubé. A scholar is included among the top collaborators of Philip E. Dubé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip E. Dubé. Philip E. Dubé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Graham, Sean W., et al.. (2023). Utilizing a human TLR selective ligand in a humanized immune system mouse model to investigate human TLR4 signaling. Journal of Biological Methods. 10(1). 1–1. 1 indexed citations
2.
Liu, Cambrian Y., et al.. (2022). Transitional Anal Cells Mediate Colonic Re-epithelialization in Colitis. Gastroenterology. 162(7). 1975–1989. 8 indexed citations
3.
Huarte, Eduardo, Michael T. Peel, Ashish Juvekar, et al.. (2021). Ruxolitinib, a JAK1/JAK2 Selective Inhibitor, Ameliorates Acute and Chronic Steroid-Refractory Gvhd Mouse Models. Immunotherapy. 13(12). 977–987. 4 indexed citations
4.
Liu, Cambrian Y., Ying Huang, Philip E. Dubé, et al.. (2020). TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice. Cell Reports. 33(3). 108275–108275. 12 indexed citations
5.
Viennois, Émilie, Alexis Bretin, Philip E. Dubé, et al.. (2020). Dietary Emulsifiers Directly Impact Adherent-Invasive E. coli Gene Expression to Drive Chronic Intestinal Inflammation. Cell Reports. 33(1). 108229–108229. 80 indexed citations
6.
Suominen, Mari I., et al.. (2019). Abstract LB-A01: Establishment of a novel prostate cancer bone metastasis model in humanized mice and early efficacy results of pembrolizumab. Molecular Cancer Therapeutics. 18(12_Supplement). LB–A01. 2 indexed citations
7.
Dubé, Philip E., et al.. (2018). Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice. Scientific Reports. 8(1). 22 indexed citations
8.
Dubé, Philip E., Rabea Alhosh, Shivesh Punit, et al.. (2017). The Role of the Microbiome in Early-Onset Colitis in an IL-10 and Tumor Necrosis Factor Receptor 1 Deficient Mouse Model. Gastroenterology. 152(5). S1001–S1001. 2 indexed citations
9.
Punit, Shivesh, et al.. (2015). Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8+ T Cells in Mice With Colitis. Gastroenterology. 149(4). 993–1005.e2. 40 indexed citations
10.
Liu, Cambrian Y., et al.. (2015). Optical reconstruction of murine colorectal mucosa at cellular resolution. American Journal of Physiology-Gastrointestinal and Liver Physiology. 308(9). G721–G735. 18 indexed citations
11.
Dubé, Philip E., Shivesh Punit, & D. Brent Polk. (2014). Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 308(3). G161–G170. 31 indexed citations
12.
Dubé, Philip E., Fang Yan, Shivesh Punit, et al.. (2012). Epidermal growth factor receptor inhibits colitis-associated cancer in mice. Journal of Clinical Investigation. 122(8). 2780–2792. 69 indexed citations
13.
Dubé, Philip E. & D. Brent Polk. (2012). Opposing Roles for EGFR in Colitis-Associated Cancer: The Presence of Active Inflammation Determines a Protective Versus Tumorigenic Role for EGFR. Inflammatory Bowel Diseases. 18. S89–S90. 1 indexed citations
14.
Zhang, Yongqin, Philip E. Dubé, M. Kay Washington, Fang Yan, & D. Brent Polk. (2011). ErbB2 and ErbB3 regulate recovery from dextran sulfate sodium-induced colitis by promoting mouse colon epithelial cell survival. Laboratory Investigation. 92(3). 437–450. 29 indexed citations
15.
Izzo, Angelo A., Katherine Rowland, Philip E. Dubé, et al.. (2010). Mechanism of Action of Glucagon-Like Peptide-2 to Increase IGF-I mRNA in Intestinal Subepithelial Fibroblasts. Endocrinology. 152(2). 436–446. 56 indexed citations
16.
Dubé, Philip E. & Patricia L. Brubaker. (2007). Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators. American Journal of Physiology-Endocrinology and Metabolism. 293(2). E460–E465. 128 indexed citations
17.
Dubé, Philip E., et al.. (2006). The Essential Role of Insulin-Like Growth Factor-1 in the Intestinal Tropic Effects of Glucagon-Like Peptide-2 in Mice. Gastroenterology. 131(2). 589–605. 150 indexed citations
18.
Chen, Liang, Peixiang Wang, Cristiano Feijó Andrade, et al.. (2005). PKA independent and cell type specific activation of the expression of caudal homeobox gene Cdx‐2 by cyclic AMP. FEBS Journal. 272(11). 2746–2759. 33 indexed citations
19.
Ferguson, Thomas A., Philip E. Dubé, & Thomas S. Griffith. (1994). Regulation of contact hypersensitivity by interleukin 10.. The Journal of Experimental Medicine. 179(5). 1597–1604. 139 indexed citations
20.
Ferguson, Thomas A., John M. Herndon, & Philip E. Dubé. (1994). The immune response and the eye: a role for TNF alpha in anterior chamber-associated immune deviation.. PubMed. 35(5). 2643–51. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hatem Masmoudi Breakdown of academic impact, for papers by Songyan Deng Breakdown of academic impact, for papers by Jose Zavala‐Solorio Breakdown of academic impact, for papers by Toshiaki Teratani Breakdown of academic impact, for papers by Brooks Scull Breakdown of academic impact, for papers by Ann Jagger Breakdown of academic impact, for papers by David Moulin Breakdown of academic impact, for papers by V. E. Eysselein Breakdown of academic impact, for papers by Blake M. Warner Breakdown of academic impact, for papers by Ulrika Islander
Rankless by CCL
2026